Influence of Intraoperative Capsule Rupture on Outcomes in Stage I Epithelial Ovarian Cancer

被引:61
作者
Bakkum-Gamez, Jamie N.
Richardson, Debra L.
Seamon, Leigh G.
Aletti, Giovanni D.
Powless, Cecelia A.
Keeney, Gary L.
O'Malley, David M.
Cliby, William A.
机构
[1] Mayo Clin, Div Gynecol Oncol, Rochester, MN USA
[2] Ohio State Univ, Coll Med, Div Gynecol Oncol, Columbus, OH 43210 USA
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
关键词
GYNECOLOGIC-ONCOLOGY-GROUP; CHROMIC PHOSPHATE P-32; PHASE-III TRIAL; ADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; NEOPLASM TRIAL; CARCINOMA; WOMEN; CISPLATIN; SURVIVAL;
D O I
10.1097/AOG.0b013e3181917a0c
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To evaluate the effect of tumor capsule rupture on disease prognosis in stage I epithelial ovarian cancer. METHODS: All patients with International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer operated on at the Mayo Clinic and The Ohio State University between January 1991 and December 2007 were identified. Relevant tumor characteristics, procedures performed, adjuvant therapies, and follow-up were recorded and analyzed. Inclusion criteria included comprehensive staging. Cox proportional hazards, Kaplan-Meier estimation, log rank test, and chi(2) test were used for statistical analyses. RESULTS: There were 161 cases that met inclusion criteria. Seventy-four (46%) patients had intact capsules without positive cytology or surface involvement; 61 (38%) had capsule rupture; 33 (20%) had positive cytology; and 22 (14%) had surface involvement. Overall, 22 of 161 (14%) patients recurred and 12 of 161 (7%) patients died of their disease. In univariable analysis, both intraoperative capsule rupture and positive cytologic washings portended worse disease-free survival (hazard ratio [HR] 3.6, 95% confidence interval [CI] 1.5-8.9; P=.004 and HR 5.2, 95% CI 2.1-12.3; P<.001, respectively) and disease-specific survival (HR 4.1, 95% CI 1.3-15.4; P=.018 and HR 5.9, 95% CI 1.8-19.3; P=.005, respectively). In multivariable analysis, capsule rupture (HR 4.2, 95% Cl 1.8-10.9; P=.001) and positive cytologic washings (HR 6.4, 95% CI 2.5-16.0; P<.001) remained independent predictors of worse disease-free survival. Disease-free survival and disease-specific survival were shortest for stage IC cases with positive cytology, surface involvement, or both, that also had intraoperative rupture. CONCLUSION: In stage I epithelial ovarian cancer, intraoperative capsule rupture portends a higher risk of disease recurrence and death from disease. Careful intraoperative removal of ovarian masses is important, and recognizing the higher-risk nature of such cases is imperative.
引用
收藏
页码:11 / 17
页数:7
相关论文
共 26 条
[1]   Natural history and prognosis of untreated stage I epithelial ovarian carcinoma [J].
Ahmed, FY ;
Wiltshaw, E ;
AHern, RP ;
Nicol, B ;
Shepherd, J ;
Blake, P ;
Fisher, C ;
Gore, ME .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :2968-2975
[2]   Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[3]  
Aletti GD, 2007, MAYO CLIN PROC, V82, P751
[4]   Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study [J].
Bell, Jeffrey ;
Brady, Mark F. ;
Young, Robert C. ;
Lage, Janice ;
Walker, Joan L. ;
Look, Katherine Y. ;
Rose, G. Scott ;
Spirtos, Nick M. .
GYNECOLOGIC ONCOLOGY, 2006, 102 (03) :432-439
[5]   Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (P-32) [J].
Bolis, G ;
Colombo, N ;
Pecorelli, S ;
Torri, V ;
Marsoni, S ;
Bonazzi, C ;
Chiari, S ;
Favalli, G ;
Mangili, C ;
Presti, M ;
Zanaboni, F ;
Mangioni, C .
ANNALS OF ONCOLOGY, 1995, 6 (09) :887-893
[6]   Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer [J].
Borgfeldt, Christer ;
Iosif, Constantin ;
Masback, Anna .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 134 (01) :110-114
[7]  
Colombo N, 2003, J NATL CANCER I, V95, P125
[8]  
DELACUESTA RS, 1994, OBSTET GYNECOL, V84, P1
[9]  
DEMBO AJ, 1990, OBSTET GYNECOL, V75, P263
[10]   Cancer statistics, 2008 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Hao, Yongping ;
Xu, Jiaquan ;
Murray, Taylor ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) :71-96